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Abstract
Background—Children with chronic kidney disease (CKD) and hypertension have increased 
blood pressure variability (BPV). Increased BPV has been associated with lower neurocognitive 
test scores in adults. Children with CKD are at risk for decreased neurocognitive function. Our 
objective was to determine if children with CKD and increased BPV had worse performance on 
neurocognitive testing compared with children with CKD and lower BPV.
Methods—This was a cross-sectional and longitudinal analysis of the relation between BPV and 
neurocognitive test performance in children 6 years and older enrolled in the Chronic Kidney 
Disease in Children (CKiD) study. Visit-to-visit BPV was assessed by the standard deviation of 
visit BPs (BPV-SD) and average real variability (ARV). Ambulatory BPV was assessed by SD of 
wake and sleep periods on 24hr ambulatory BP monitoring.
Results—650 subjects had a mean follow-up period of 4.0 years. Subjects with systolic visit-to-
visit BPV in the upper tertile had lower scores on Delis–Kaplan Executive Function System (D-
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KEFS) Verbal Category Switching than those with BPV in the lower tertile (BPV-SD, 8.3 vs. 9.5, 
p = 0.006; ARV, 8.5 vs. 9.6, p = 0.02). On multivariate analysis, the association between lower 
Category Switching score and increased BPV remained significant after controlling for mean BP, 
demographic characteristics, and disease-related variables (BPV-SD, β = −0.7, 95% confidence 
interval [CI]: −1.28 to −0.12; ARV, CI: −1.05 to −0.02). Ambulatory BPV was not independently 
associated with any cognitive measure.
Conclusions—Higher systolic visit-to-visit BPV was independently associated with decreased 
D-KEFS Category Switching scores in children with mild-to-moderate CKD.
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Hypertension; pediatric; neuropsychological testing; kidney; CKD
INTRODUCTION
In adults, alterations in blood pressure (BP) can have negative cardiovascular effects, not 
only through elevations of mean BP, but also through increases in blood pressure variability 
(BPV). BPV can be defined either in the short term, as measured by variability in 
measurements within a 24 hour period during ambulatory BP monitoring (ambulatory BPV), 
or in the long term as variability in office visit measurements over time (visit-to-visit BPV) 
[1]. Studies show that increases in both short term and long term BPV are associated with 
increases in hypertensive target organ damage, cardiovascular events, all-cause mortality, 
and faster progression of chronic kidney disease (CKD) [2–6].
Increased BPV may also affect neurocognitive function. In adults, visit-to-visit BPV and 
ambulatory BPV have both been associated with lower scores in global cognition, executive 
function, attention, processing speed and memory in the elderly [7–10]. Long term visit-to-
visit BPV was evaluated over 25 years in a young adult cohort and was associated with 
worse psychomotor speed and verbal memory in midlife, independent of cumulative BP 
exposure [11].
Recently, ambulatory BPV was evaluated in children with mild-to-moderate CKD. Children 
with CKD who were hypertensive were found to have increased BPV compared with those 
who were normotensive [12]. Children with CKD are frequently hypertensive and are at risk 
for decreased neurocognitive function [13]. To our knowledge, the potential impact of 
increased BPV on cognition in children with CKD has not been previously evaluated. The 
objective of the current study was to evaluate the impact of BPV on cognition in children 
with mild-to-moderate CKD.
METHODS
Participants
Subjects were participants in the Chronic Kidney Disease in Children Study (CKiD), a 
longitudinal, observational cohort study of children with CKD being conducted at 48 
pediatric nephrology centers in North America. Enrollment criteria for CKiD have been 
published and include age 1 to 16 years and Schwartz-estimated GFR (eGFR) of 30 to 90 
Lande et al. Page 2
Pediatr Nephrol. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
ml/min per 1.73 m2, without solid organ, bone marrow, or stem cell transplant; dialysis 
treatment within 3 months before enrollment; cancer/leukemia or HIV treatment; and 
pregnancy [14]. This study is an analysis of CKiD subjects age 6 years and above for whom 
both neurocognitive data and BP measurements were available and for whom there was at 
least 2 years of BP data (3 visits). Subjects younger than 6 years were administered a 
different neurocognitive test battery and were therefore excluded. CKiD study visits 
occurred at study entry, at 6 months, and then annually from the time of initial enrollment, 
with neurocognitive assessments occurring 6 months after enrollment, at 24 months, and 
then every two years thereafter.
Measurements
Casual Blood Pressure Measurement—Casual BP measurements were obtained in 
the right arm by auscultation at each study visit by trained examiners. Training was repeated 
annually. Three BP measurements were obtained by auscultation of the brachial artery using 
the first Korotkoff sound for systolic BP (SBP) and the fifth Korotkoff sound for diastolic 
BP (DBP). The average of the three BP measurements was recorded as the participant’s BP 
for the study visit [15].
Ambulatory BP Monitoring
Twenty-four hour ambulatory BP monitoring (ABPM) was performed at 6 months and then 
every 2 years. For each 24hr recording, measurements were obtained every 20 minutes 
through the day and night at a bleed step of 8 mm/Hg. A diary was kept during the 
monitoring to record sleep and wake times. ABPM studies were considered successful only 
when at least one successful BP measurement was obtained during each hour of monitoring 
and the overall success rate was at least 75 %. The means of SBP and DBP were determined 
for wake and sleep periods. BP index was defined as the mean BP divided by the 95th 
percentile for that subject. Normative data for ABPM were based on American Heart 
Association recommendations on ABPM for children and adolescents [16].
Blood Pressure Variability
Long-term BPV was assessed by visit-to-visit variability, using the mean casual BP 
measurement from each study visit leading up to and including the visit of the most recent 
neurocognitive assessment for each subject. Because of subject age and study vintage, the 
number of BP observations differed between subjects. Visit-to-visit BPV was assessed by 
two methods: 1) the standard deviation of visit BPs (BPV-SD), and 2) average real 
variability (ARV), with all BPs indexed to the 95th percentile for age, gender, and height for 
that subject [17]. The ARV method quantifies variability between adjacent readings and is 
defined by the following formula [6];
Short term BPV was evaluated using the ABPM session done prior to the most recent 
neurocognitive testing. ABPM and neurocognitive assessments were not done concurrently 
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at any point in the CKiD study; by study design ABPM sessions and neurocognitive 
assessments were separated by 6 to 12 months. Ambulatory variability was measured as the 
standard deviation of the mean SBP and DBP for the wake and sleep periods [12]. Standard 
deviation of the 24hr mean BP was not used since that time period includes the nocturnal 
dip. All ambulatory BP measures were indexed to the 95th percentile for gender and height 
according to ambulatory norms [18].
Neurocognitive Assessments
This analysis evaluated subject performance on selected measures from the CKiD 
neurocognitive test battery, including Wechsler Abbreviated Scales of Intelligence (WASI) 
Matrix Reasoning subtest, Conners’ Continuous Performance Test-II (CPT-II) commission 
errors, and parent-rated Behavior Rating Inventory of Executive Function Global Executive 
Composite (BRIEF GEC). These measures were chosen because it was previously shown 
that CKiD participants were most likely to score more than 1 to 1.5 SD below the normative 
mean on these measures, and they are measures that have been used throughout all the years 
of the CKiD study [13]. In addition, based on the literature on hypertension and cognition, 
Wechsler Intelligence Scale for Children-IV (WISC-IV) Digit Span and Delis–Kaplan 
Executive Function System (D-KEFS) Verbal Fluency (Letter Fluency, Category Fluency, 
Category Switching) were included as measures of working memory and cognitive speed/
efficiency. All of the assessments were administered or supervised by a licensed 
psychologist who was not aware of the subject’s BP status. To ensure quality control, 
neurocognitive data for the first two cases completed at each clinical site were reviewed by 
the Clinical Coordinating Center neuropsychologists. Thereafter, 25 % of the assessments 
were reviewed to verify administration fidelity, scoring accuracy, accuracy of translation of 
raw scores into standardized scores, and accuracy of transcription. All of the measures in the 
neurocognitive battery have good to excellent ratings of reliability [19].
Analysis
The data in this report are reported as the means ± SD, medians with interquartile ranges, or 
frequencies and percentages, as appropriate. To address the primary research question, 
whether children with increased BPV have poorer performance in measures of 
neurocognitive function, test scores of the subjects with BPV in the upper tertile were 
compared to those in the lower tertile in unadjusted analysis using 2-sided t tests. Systolic 
BPV and diastolic BPV were analyzed separately. For each neurocognitive measure, the 
score at the most recent neurocognitive assessment was evaluated so that the complete 
observed history of BP measurements could be utilized. For cognitive measures with 3 or 
more values over time, the annual change in score was also evaluated. This was not the case 
for D-KEFS Verbal Fluency as it was added to the neurocognitive battery relatively recently, 
thus limiting our ability to assess the annual change over time for that task. The D-KEFS 
Category Switching scores were reported as Switching Total score, the average of Accuracy 
and Total Correct scaled scores, since these scores correlated closely in our sample, 
indicating overlap of the cognitive abilities being tested.
To assess the association between BPV and neurocognitive performance, multiple linear 
regression was performed for each neurocognitive measure found to be different between the 
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BPV groups. In the models for visit-to-visit variability, the main predictor was 
log2-transformed (BPV-SD or ARV), so the estimate can be interpreted as the change in 
neurocognitive outcome per doubling of BPV-SD or ARV. In the models for ambulatory 
variability, the main predictor is log2(ABPM SD), so the estimate can be interpreted as the 
change in neurocognitive outcome per doubling of SD, adjusted for the covariates. The 
multivariate analyses used all available BPV data, including the middle tertile, and evaluated 
the log linear relation between BPV and neurocognitive measures. Other variables controlled 
for in the regression models included mean corresponding BP index, sex, age, maternal 
education, African-American race, body mass index (BMI) percentile, eGFR [20], 
percentage of life with CKD, nephrotic proteinuria, and low birth weight. The significance 
level for all data analyses was set at p < 0.05. SAS 9.2 (SAS Institute, Cary, NC) and S-Plus 
8.2 (TIBCO Software, Palo Alto, CA) were used for analysis and figure generation.
RESULTS
Sample Characteristics
The study sample comprised 650 participants. At the time of the most recent neurocognitive 
assessment, the median age was 15.4 years, median duration of study follow-up was 4.0 
years, and the median number of visits with casual BP measurement was 6. The sample was 
62 % male, 22 % African-American, and the median eGFR was 47 ml/min/1.73m2. Table 1 
shows sociodemographic and kidney disease-related characteristics of the sample. Figure 1 
shows the median values and distribution of visit-to-visit systolic and diastolic BPV by both 
the BP-SD and ARV methods.
Visit-to-visit BPV and Neurocognitive Test Performance - Analysis of the most recent 
neurocognitive assessment
The number of subjects in each analysis varied by the particular neurocognitive test, ranging 
from 279 for D-KEFS Category Switching to 622 for parent BRIEF GEC. Bivariate analysis 
using the most recent neurocognitive assessment revealed that subjects with systolic visit-to-
visit BPV in the upper tertile had lower scores (worse performance) on D-KEFS Verbal 
Category Fluency and Category Switching compared with subjects with BPV in the lower 
tertile, by both BPV-SD and ARV. In contrast, there was no significant difference between 
systolic visit-to-visit BPV groups in any other neurocognitive measure (Table 2 and 3). 
Multivariate linear regression analysis showed that increased systolic visit-to-visit BPV 
remained independently associated with lower scores on the D-KEFS Verbal Category 
Switching task for both BPV-SD and ARV, but not for Category Fluency (Table 4). Because 
Category Switching was performed in only 279 subjects, we examined the difference in 
demographics between those subjects with Category Switching and those who did not have 
Category Switching performed (n = 371). Subjects with Category Switching had less 
nephrotic proteinuria (11 % vs. 23 %, p <0.001), slightly shorter follow-up (3.8 vs. 4.1 
years, p = 0.03), slightly lower average SBP index (0.87 vs. 0.87, p = 0.04), higher eGFR 
(56 vs. 36, p <0.001), and less percentage of life with CKD (100 vs. 100 %, p = 0.04). We 
adjusted for all of these demographic characteristics in the multivariate analyses. The group 
with Category Switching also had a lower proportion of subjects with systolic BPV in the 
upper tertile (BPV-SD, 27 vs 38 %, p = 0.02; ARV, 29 vs 36 %, p = 0.02).
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With regard to diastolic visit-to-visit BPV, bivariate analysis showed no difference between 
groups for most measures, except a small difference in CPT-II commission errors (1st tertile 
vs. 3rd tertile, 50.7 ± 12.4 vs. 52.6 ± 10.9, p = 0.04) for ARV, but not BPV-SD. However, the 
difference by ARV did not remain significant after adjustment for covariates on multivariate 
linear regression (β = −1.51, p = 0.07).
Visit-to-visit BPV - Analysis of the annual change in neurocognitive test performance
Subjects with systolic visit-to-visit BPV in the upper tertile had slightly different annual 
change in scores on the parent BRIEF GEC compared with subjects with BPV in the lower 
tertile. However, these differences did not remain significant after adjustment for covariates 
on multivariate linear regression (BPV-SD, β = −0.29, p = 0.35; ARV, β = −0.38, p = 0.16). 
There were no other differences on bivariate analysis of systolic or diastolic BPV for any 
neurocognitive measure using annual change in scores (data not shown). We were not able to 
analyze the annual change in D-KEFS Verbal Fluency scores as too few subjects had at least 
3 study visits with that measure.
Ambulatory BPV
On analysis of the relation between ambulatory BPV and the most recent neurocognitive 
assessment, the only statistically significant difference was for WASI Digit Span Forward 
(systolic sleep, 1st vs. 3rd tertile, 8.0 ± 2.7 vs. 9.0 ± 3.0, p = 0.01; diastolic wake, 7.9 ± 2.8 
vs. 9.0 ± 2.7, p = 0.005). However, these differences did not remain significant after 
adjustment for covariates on multivariate linear regression (systolic sleep, β = 0.48, p = 0.27; 
diastolic wake, β = 0.99, p = 0.11). On analysis of the relation between ambulatory BPV and 
the annual change in neurocognitive test performance, the only statistically significant 
difference was for the annual change in BRIEF GEC for systolic sleep (1st vs. 3rd tertile, 
−0.13 ± 2.21 vs. −1.30 ± 2.80, p = 0.01). However, this difference did not remain significant 
after adjustment for covariates on multivariate linear regression (β = −0.44, p = 0.34). There 
was no difference for any other neurocognitive measure for any ABPM parameter (full data 
for the ABPM bivariate and multivariate analyses are available in the Electronic 
Supplementary Tables 1a–d and 2a–d).
DISCUSSION
This study was conducted to determine whether children with CKD and increased BPV had 
poorer performance on selected tests of neurocognitive function when compared to the 
performance of children with CKD and lower BPV, and to examine the relative contribution 
of BPV to neurocognitive outcomes, taking into account mean BP and sociodemographic 
and disease-related variables. The results showed that increased visit-to-visit systolic BPV in 
children with mild-to-moderate CKD was independently associated with lower scores 
(worse performance) on the Category Switching Task of the D-KEFS Verbal Fluency Test by 
both BPV-SD and ARV.
In contrast, increased systolic visit-to-visit BPV was not associated with performance on any 
of the other measures. No relation was uncovered between neurocognitive test performance 
and diastolic visit-to-visit BPV in this sample. In contrast to the finding of an association 
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between systolic visit-to-visit BPV and worse neurocognitive test performance, we did not 
find any independent relation between ambulatory BPV and any neurocognitive measure. 
However, these results were limited by the fact that the ABPM sessions in CKiD were 
obtained 6 – 12 months apart from the neurocognitive testing, by study design. In addition, it 
has been shown that the correlation between visit-to-visit BPV and ambulatory BPV is 
weak, suggesting that they are not interchangeable entities [21].
The D-KEFS Verbal Fluency Test was included in the current study because both CKD and 
primary hypertension in adults have been associated with performance deficits in 
neurocognitive measures of cognitive efficiency and processing speed [22, 23]. The 
Category Switching subtest of the D-KEFS Verbal Fluency Test requires the subject to 
alternate between saying words from two different semantic categories. Category switching 
falls within a group of executive function tasks called set shifting, the mental ability to adjust 
thinking or attention in response to changing expectations, goals, or environmental stimuli 
[24]. The finding that children with CKD and increased long term BPV had worse 
performance on the Category Switching Task suggests that children with CKD may have 
difficulties with this component of executive functioning that are related, in part, to 
increased BPV.
This study has several limitations. Because D-KEFS Verbal Fluency was added to the CKiD 
neurocognitive test battery only recently, we could not analyze the relationship between 
increased BPV and the longitudinal annual change of Category Switching over time. 
Therefore, the cross sectional nature of that part of the analysis limits inference about 
causality between increased BPV and lower Category Switching scores. Although the 
relation between increased BPV and lower Category Switching scores is intriguing, it is an 
isolated finding. Other measures of verbal speed/cognitive efficiency and set shifting will 
need to be examined in relation to elevated BPV in order to support the findings obtained 
from this study. Nonetheless, our previous work suggests that measures of executive 
function may be most sensitive to the effects of childhood CKD [25]. We excluded children 
less than 6 years old. While younger age is associated with lower systolic BPV in children 
with CKD [12], to our knowledge the effect of age on BPV in children with CKD who are 
less than six years old has not been reported. Lastly, because the effects of BP on 
neurocognitive test performance are known to be subtle, we did not adjust the bivariate 
analysis for multiple comparisons. Although this approach permits the detection of more 
subtle differences, it could increase the risk of a type 1 error.
In summary, we report the novel finding of an association between higher systolic visit-to-
visit BPV and poorer neurocognitive function in children with CKD. This finding is 
particularly notable given the mild-to-moderate degree of CKD in the participants. Further 
studies are warranted to determine the significance of this isolated finding. The results are of 
potential clinical significance, in that some antihypertensive medications lower BPV as well 
as mean BP level [26]. Confirmation of these findings would raise the question as to whether 
treating hypertension with medications that ameliorate BPV as well as lower mean BP level 
would improve cognition, particularly cognitive flexibility, in children with CKD.
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Figure 1. 
Median values and distribution of visit-to-visit systolic and diastolic BPV for both BP-SD 
and ARV. All BPs were indexed to the 95th percentile for age, gender, and height for that 
subject. The middle tertile is shaded in grey.
BPV: Blood pressure variability, BPV-SD: standard deviation of visit BPs, ARV: average 
real variability, DBP: diastolic blood pressure, SBP: systolic blood pressure
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Table 1
Demographic and kidney disease-related characteristics
Characteristic Value
Age, y (median, IQR) 15.4 [12.1, 18]
Male (%, n) 62% (403)
African-American race (%, n) 22% (140)
Low birth weight (<2500 g) (%, n) 19% (117)
BMI percentile (median, IQR) 64 [31, 90]
eGFR (median, IQR) 47 [30, 64]
Nephrotic proteinuria (uP/C > 2) (%, n) 18% (107)
Glomerular etiology (%, n) 26% (167)
Percent of life with CKD (median, IQR) 100% [82%, 100%]
Years in study (median, IQR) 4.0 [2.1, 6.1]
Number of study visits (median, IQR) 6 [4, 8]
SBP Index (median, IQR) 0.87 [0.83, 0.92]
DBP Index (median, IQR) 0.82 [0.76, 0.88]
SBP or DBP ≥ 90th percentile
 at most recent visit 152 (24%)
 at any study visit 385 (59%)
Antihypertensive medication use (any) 463 (71%)
 ACE inhibitor/ARB 363 (56%)
 Calcium Channel Blocker 119 (18%)
 Other 102 (16%)
ACE: Angiotensin converting enzyme, ARB: Angiotensin receptor blocker, BMI: Body mass index, CKD: chronic kidney disease, DBP: diastolic 
blood pressure, eGFR: estimated glomerular filtration rate, IQR: interquartile range, SBP: systolic blood pressure
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Table 4
The association of increased indexed visit-to-visit BPV and Verbal Category Fluency and Category Switching 
scores in separate multiple linear regression analyses for systolic BPV-SD and ARV.
Neurocognitive Variable (at most recent visit) N Visit-to-visit systolic BPV
Estimate 95% CI p-value
Category Fluency 222
 BPV-SD −0.21 (−0.92, 0.51) 0.57
 ARV −0.32 (−0.96, 0.32) 0.33
Category Switching 220
 BPV-SD −0.70 (−1.28, −0.12) 0.02
 ARV −0.54 (−1.05, −0.02) 0.04
*All regression models adjusted for mean corresponding BP index, sex, age, maternal education, African-American race, BMI percentile, eGFR, 
percent of life with CKD, nephrotic proteinuria, and low birth weight.
ARV: average real variability, BMI: body mass index, BP: blood pressure, BPV: blood pressure variability, BPV-SD: standard deviation of visit 
BPs, CI: confidence interval, CKD: chronic kidney disease, eGFR: estimated glomerular filtration rate
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